Strs Ohio Acquires 1,900 Shares of Evolent Health, Inc. (NYSE:EVH)

Strs Ohio boosted its position in Evolent Health, Inc. (NYSE:EVH) by 46.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,000 shares of the technology company’s stock after purchasing an additional 1,900 shares during the period. Strs Ohio’s holdings in Evolent Health were worth $198,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of EVH. Nisa Investment Advisors LLC boosted its position in Evolent Health by 389.3% in the third quarter. Nisa Investment Advisors LLC now owns 5,035 shares of the technology company’s stock worth $137,000 after purchasing an additional 4,006 shares during the last quarter. Teacher Retirement System of Texas boosted its position in Evolent Health by 9.0% in the third quarter. Teacher Retirement System of Texas now owns 8,293 shares of the technology company’s stock worth $226,000 after purchasing an additional 685 shares during the last quarter. Altshuler Shaham Ltd boosted its position in Evolent Health by 25.0% in the third quarter. Altshuler Shaham Ltd now owns 15,000 shares of the technology company’s stock worth $408,000 after purchasing an additional 3,000 shares during the last quarter. Amalgamated Bank boosted its position in Evolent Health by 9.7% in the third quarter. Amalgamated Bank now owns 17,023 shares of the technology company’s stock worth $464,000 after purchasing an additional 1,500 shares during the last quarter. Finally, Values First Advisors Inc. purchased a new position in Evolent Health in the third quarter worth about $481,000.

Evolent Health Stock Down 0.2 %

NYSE EVH opened at $27.76 on Wednesday. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.56. Evolent Health, Inc. has a 12 month low of $23.33 and a 12 month high of $36.70. The stock’s 50 day moving average is $31.71 and its 200 day moving average is $30.29. The stock has a market cap of $3.20 billion, a PE ratio of -21.84 and a beta of 1.54.

Evolent Health (NYSE:EVH) last released its quarterly earnings data on Thursday, February 22nd. The technology company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.13. Evolent Health had a positive return on equity of 6.60% and a negative net margin of 5.76%. The business had revenue of $556.06 million for the quarter, compared to the consensus estimate of $541.87 million. Research analysts predict that Evolent Health, Inc. will post 0.87 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Oppenheimer started coverage on Evolent Health in a research report on Friday, March 1st. They issued an “outperform” rating and a $45.00 target price on the stock. William Blair reaffirmed an “outperform” rating on shares of Evolent Health in a research report on Tuesday, January 9th. JPMorgan Chase & Co. lowered their price objective on Evolent Health from $53.00 to $52.00 and set an “overweight” rating on the stock in a research report on Friday, March 15th. Barclays started coverage on Evolent Health in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $39.00 price objective on the stock. Finally, Citigroup started coverage on Evolent Health in a research report on Monday, April 22nd. They set a “buy” rating and a $40.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $42.70.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.